Recap: Esperion Therapeutics Q3 Earnings

Recap: Esperion Therapeutics Q3 Earnings

Esperion Therapeutics ESPR reported its Q3 earnings results on Tuesday, November 1, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.


Esperion Therapeutics beat estimated earnings by 12.9%, reporting an EPS of $-0.81 versus an estimate of $-0.93.

Revenue was up $4.57 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.12 which was followed by a 1.7% drop in the share price the next day.

Here's a look at Esperion Therapeutics's past performance:


Quarter Q2 2022 Q1 2022 Q4 2021 Q3 2021
EPS Estimate -0.93 -1.04 -2.27 -2.79
EPS Actual -1.05 -0.93 -1.77 -2.62
Revenue Estimate 18.71M 15.39M 14.47M 12.85M
Revenue Actual 18.84M 18.84M 15.40M 14.41M

To track all earnings releases for Esperion Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: BZI-RecapsEarnings